University of Vermont

The University of Vermont Cancer Center

trials_hemat.html

Hematologic Malignancy Cancer Clinical Trials

The University of Vermont Cancer Center has many trials specifically focused on hematologic malignancy cancer research.

Status: Active - Recruiting
Study Title:
COG AAML08B1 - Biology Study of Transient Myeloproliferative Disorder (TMD) in Children with Down Syndrome (DS)
Purpose: This research study is looking at blood samples from newborns with Down syndrome.
ClinicalTrials.gov Identifier: NCT00959283
Primary/Site/Co Investigator: Alan C. Homans, MD
Contact: Alan Homans (802) 847-2850
Information: http://www.clinicaltrials.gov/ct2/show/NCT00959283?term=COG+AAML08B1&rank=1
Institution Number: M11-185
Protocol Research Type: Cooperative Group

Last modified December 05 2014 11:48 AM